MedPath

Analgesic Effect of Breastmilk for Procedural Pain in Preterm Infants

Phase 3
Conditions
Procedural Pain
Registration Number
NCT00908401
Lead Sponsor
Centre Hospitalier Intercommunal Creteil
Brief Summary

Hypothesis: Breastmilk has a more powerful analgesic effect than oral sucrose to avoid procedural pain in preterm neonates.

The objective is to test this hypothesis in a randomized, controlled study using a standardized and validated pain scale (DAN). The sample size is 21 preterm infants in each two groups. The main end point is a reduction of the risk to have a DAN superior to 1 from 80% with oral sucrose to 40% with breastmilk.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
42
Inclusion Criteria
  • preterm neonates born before 27 and 29+6 weeks GA
  • blood sampling procedure
  • obtention of parental consent
Exclusion Criteria
  • congenital malformation
  • intravenous continuous analgesia
  • contraindications to feed
  • high grade intracerebral hemorrhage

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Decrement from 80 to 40% of frequency of DAN's scale score superior to 1 using breastmilk instead of oral sucroseOne time during day 3 or 4 then day 7 to 10
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Centre Hospitalier Intercommunal de Creteil

🇫🇷

Creteil, France

Centre Hospitalier Intercommunal de Creteil
🇫🇷Creteil, France
Elodie Zana, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.